ACVBP outdoes CHOP/radiotherapy in low-risk aggressive lymphoma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1482, 2005-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab plus CHOP advances in aggressive NHL

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Rituximab plus CHOP induction beneficial in aggressive NHL

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Treatment of AIDS Related Non-Hodgkin's Lymphoma with Combination Mitoguazone Dihydrochloride and Low Dose Chop Chemotherapy: Results of a Phase II study

By Tulpule Anil Espina Byron M. Pedro Santabarbara A. B. Palmer Maria Schiflett Joanne Boswell William Smith Susan Levine Alexandra M.

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 63-68

Springer Publishing Company

Access to resources Recommend Favorite

Dose-intensified CHOP ± etoposide in non-Hodgkin's lymphoma

Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Intensive chemotherapy + stem cells superior to CHOP in lymphoma

Inpharma, Vol. 1, Iss. 1431, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite